UPDATED Aug 13, 2022
These companies have already demonstrated past earnings growth, and analysts are forecasting further income growth. We've excluded mining and oil stocks because they are very cyclical.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AVTRAvantor | US$28.56 | 0.03% | -26.0% | US$19.3b | US$37.53 | PE33.6x | E21.6% | n/a | Pharmaceuticals & Biotech | ||
LSCCLattice Semiconductor | US$63.51 | -1.6% | 7.8% | US$8.7b | US$75.13 | PE64.2x | E23.0% | n/a | Semiconductors | ||
CELHCelsius Holdings | US$105.16 | 6.6% | 44.8% | US$8.0b | US$116.00 | PE432.1x | E56.9% | n/a | Food, Beverage & Tobacco | ||
SYNHSyneos Health | US$68.88 | 1.4% | -21.3% | US$7.1b | US$79.00 | PE25.4x | E17.4% | n/a | Pharmaceuticals & Biotech | ||
HRMYHarmony Biosciences Holdings | US$52.15 | -0.7% | 62.2% | US$3.1b | US$61.50 | PE53.1x | E44.6% | n/a | Pharmaceuticals & Biotech | ||
LESLLeslie's | US$15.97 | 5.1% | -33.8% | US$2.9b | US$19.09 | PE20.1x | E9.9% | n/a | Retail | ||
CLFDClearfield | US$118.24 | 6.4% | 188.2% | US$1.6b | US$103.00 | PE40.9x | E10.4% | n/a | Tech | ||
DFHDream Finders Homes | US$12.91 | 2.3% | -38.6% | US$1.2b | US$12.83 | PE7x | E16.0% | n/a | Consumer Durables | ||
PERIPerion Network | US$21.87 | 5.9% | 20.2% | US$971.5m | US$31.53 | PE15.4x | E17.9% | n/a | Media | ||
IMXIInternational Money Express | US$24.53 | -1.8% | 40.8% | US$900.3m | US$27.40 | PE17.2x | E18.8% | n/a | Software | ||
ONEWOneWater Marine | US$39.93 | 1.9% | -8.3% | US$621.4m | US$51.83 | PE4.4x | E15.0% | n/a | Retail | ||
LOVELovesac | US$38.63 | 11.6% | -39.1% | US$584.3m | US$94.83 | PE12.8x | E31.2% | n/a | Consumer Durables | ||
VTRUVitru | US$17.58 | 7.5% | 2.2% | US$502.5m | US$20.03 | PE35.1x | E35.5% | n/a | Consumer Services | ||
CECECECO Environmental | US$9.67 | 20.1% | 43.3% | US$333.6m | US$12.75 | PE46.8x | E28.1% | 0% | Commercial Services | ||
IIIInformation Services Group | US$6.10 | -20.4% | -10.8% | US$293.5m | US$10.33 | PE16.4x | E15.9% | 2.6% | Software | ||
ELAEnvela | US$8.05 | 4.1% | 84.6% | US$216.7m | US$11.00 | PE17.5x | E17.5% | n/a | Retail | ||
CSBRChampions Oncology | US$9.47 | 8.6% | -12.2% | US$128.1m | US$15.67 | PE233.7x | E92.0% | n/a | Pharmaceuticals & Biotech |